Related Experiment Video
Updated: Aug 8, 2026
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014
Cancer vaccines. Part 2
1M.D. Anderson Cancer Center, Houston, Tex., USA.
Abstract:
Cancer vaccines are being widely studied for the purpose of immune modulation and subsequent antitumor effects. This article cites only a few examples of the many studies underway. Many vaccines have shown efficacy in eliciting systemic responses with minimal toxicities. The use of vaccines as a modality of cancer therapy in combination with chemotherapy, surgery, and radiation therapy is also being investigated. Although the routine use of approved vaccines is still a goal for the future, instituting this fourth modality of cancer therapy is not too distant. Phase III trials with both melanoma and colon cancer vaccines have been completed. Synthetic carbohydrate antigen vaccines have shown efficacy in several tumor types during Phase II trials and are also generating enthusiasm. The potential impact of vaccine therapy on the profession of pharmacy may involve patient counseling regarding management of side effects and possibly also dispensing of vaccine therapy products to patients directly for home administration. As ambulatory sites open in conjunction with pharmacy services and pharmacists obtain prescribing authority, pharmacists' active involvement in vaccine counseling and administration seems likely.
Insights
Cancer vaccines show promise for immune modulation and antitumor effects, with ongoing trials exploring their use alongside traditional therapies. Future integration into pharmacy practice for patient counseling and administration is anticipated.
Area of Science:
- Oncology
- Immunology
- Vaccinology
Background:
- Cancer vaccines are under extensive investigation for their potential to modulate the immune system and induce antitumor responses.
- Current research explores vaccines as a complementary cancer therapy alongside chemotherapy, surgery, and radiation.
- While widespread approval is pending, cancer vaccines represent a rapidly advancing frontier in oncology.
Purpose of the Study:
- To review the current landscape of cancer vaccine research and development.
- To highlight the efficacy and safety of various vaccine types, including synthetic carbohydrate antigen vaccines.
- To explore the potential integration of cancer vaccines into clinical practice and their impact on pharmacy services.
Main Methods:
- Review of ongoing and completed clinical trials (Phase II and III) for various cancer vaccines.
- Analysis of systemic responses and toxicities associated with vaccine administration.
- Examination of potential combination therapies involving cancer vaccines.
Main Results:
- Many cancer vaccines demonstrate efficacy in eliciting systemic immune responses with acceptable toxicity profiles.
- Phase III trials for melanoma and colon cancer vaccines have concluded, with promising Phase II results for synthetic carbohydrate antigen vaccines in multiple tumor types.
- Vaccine therapy is being actively investigated as a fourth modality of cancer treatment.
Conclusions:
- Cancer vaccines are nearing the stage of routine clinical use, offering a new therapeutic avenue.
- The evolving role of pharmacists in patient counseling and potential direct dispensing of vaccines is highlighted.
- The integration of cancer vaccines into standard care is anticipated in the near future, potentially transforming cancer treatment paradigms.
Related Concept Videos
02:59Cancer Prevention
Some...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:59Cancer Prevention
Some...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:27Tumor Immunotherapy
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...